Suggestions
Margaretta Colangelo
Leading AI Analyst | Top Thought Leadership Voice | AI Newsletter with 55,000+ subscribers
Margaretta Colangelo is a distinguished AI analyst renowned for her comprehensive expertise in business, science, and technology. With a focus on forecasting technology innovations and monitoring AI advancements in healthcare, she is a thought leader in the field.
Margaretta is the mastermind behind the AI In Healthcare Milestones Newsletter, which has gained immense popularity reaching over 80,000 subscribers. Her insightful industry reports and articles, exceeding 500 in number, have been featured in prestigious publications like Forbes and MIT Technology Review Italia, garnering a vast readership of over 8 million.
Having amassed a substantial following of over 49,000 on LinkedIn, Margaretta's influence extends internationally. She is a sought-after speaker who has presented at various prestigious events across the globe, including countries like the US, UK, Singapore, Italy, and India.
In terms of education, Margaretta pursued her BA at Sweet Briar College, building a strong academic foundation. She also attended Kent School and Convent & Stuart Hall to further enrich her knowledge and skills.
Throughout her career, Margaretta has held key positions in several renowned organizations. She contributed as a Forum Member at OpenAI and served as an Advisory Board Member at esteemed institutions like the AI Precision Health Institute at the University of Hawai'i Cancer Center and the Kitalys Institute. Additionally, she has managed leadership roles at Margaretta Colangelo Ventures, Ministry of National Guard Health Affairs (MNG-HA), International Financial Services Centres Authority, Robots Go Mental, Jthereum Corporation, U1 Technologies, LearningPatterns Inc, Nuance, esurance, and Open Horizon, Inc.
Margaretta Colangelo's vast experience, coupled with her impressive track record of contributions to the AI and healthcare sectors, solidifies her standing as an influential figure in the industry.
Highlights
AI Detects 29% More Cancer In Largest Randomized Trial Of Medical AI https://t.co/bwiABm78hd #AI #Cancer #Radiology #medicalAI https://t.co/2xHMjepeYs

AI Detects 29% More Interval Cancer In Largest Randomized Trial Of Medical AI https://t.co/lD1F6Dxa0h @lunduniversity #AI #Cancer @TheLancet @TheLancetOncol #breastcancer https://t.co/Fx1haB9Qo5

